Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. (Q48339651)
Jump to navigation
Jump to search
scientific article published in September 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. |
scientific article published in September 2010 |
Statements
1 reference
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. (English)
1 reference
Matthew Brams
1 reference
Thomas E Brown
1 reference
Joseph Gao
1 reference
Maria Gasior
1 reference
1 September 2010
1 reference
1 reference
122
1 reference
5
1 reference
7-17
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference